hypothyroidism
HYPOTHYROIDISM
Hypothyroidism is a common endocrine disorder where in the thyroid does not make enough thyroid hormone.
Subclinical/mild hypothyroidism refers to the state of slightly increased serum TSH with normal serum FT4 in patients who are usually asymptomatic.
Most common cause of primary hypothyroidism is autoimmune thyroiditis or Hashimoto's disease.
Levothyroxine is the first-line agent for treatment of hypothyroidism.

Pharmacotherapy

Levothyroxine

  • 1st-line agent for treatment of hypothyroidism
  • May be used to manage myxedema coma
  • Safe for use in pregnancy
  • Actions:
    • Used as a replacement therapy in hypothyroidism to suppress TSH secretion
    • Long T½, slow onset, regular bioconversion which is appropriately regulated by the tissues to the biologically active compound T3
  • Effects: Safe & predictable effects
    • Requires several wk to achieve peak therapeutic effects w/ regular oral dosing
  • Due to different bioavailability of the various preparations of Levothyroxine, patients are encouraged to use the same brand of Levothyroxine
    • If a change in brand is needed, the patient’s serum TSH should be retested & dosage of Levothyroxine be re-titrated

Liothyronine

  • Actions:
    • Short T½, rapid onset
    • Biologically active compound (no conversion is necessary)
    • Used as a replacement therapy in hypothyroidism to suppress TSH secretion
  • Generally not recommended for routine treatment of hypothyroidism due to its rapid onset & turnover which requires more frequent administration & increases the risk of hyperthyroidism
  • Useful in management of myxedema coma (when its rapid onset & short duration of action are required)
  • Effects: Require 3 days to achieve peak therapeutic effects
Note: Desiccated thyroid hormones (w/ variable proportion of T3 & T4), combinations of thyroid hormones & T3 alone are generally not recommended for treatment of hypothyroidism.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jun 2015
Long-term oral testosterone undecanoate significantly improved IPSS quality of life scores in a 1-year, randomised, multicentre, double-blind trial among aging hypogonadal men.
Rachel Soon, 01 Jun 2016

The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Rachel Soon, 01 Jun 2016

Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Prof. Cyrus Rustam Kumana, 07 Jul 2016

This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.